Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas-Reference-Cited by-同舟云学术

Altered Expression of TFF-1 and CES-2 in Barrett's Esophagus and Associated Adenocarcinomas

Published:2005-04 Issue:4 Volume:7 Page:407-416
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Fox Charles A.,Sapinoso Lisa M.,Zhang Hong,Zhang Wanghai,McLeod Howard L.,Petroni Gina R.,Mullick Tarun,Moskaluk Christopher A.,Frierson Henry F.,Hampton Garret M.,Powell Steven M.

Publisher

Elsevier BV

Subject

Cancer Research

Reference57 articles.

1. Rising incidence of adenocarcinoma of the esophagus and gastric cardia [comment];Blot;JAMA,1991

2. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction;Pera;Gastroenterology,1993

3. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma [see comment];Lagergren;N Engl J Med,1999

4. Genetic pathways involved in the progression of Barrett's metaplasia to adenocarcinoma;Jenkins;Br J Surg,2002

5. Cellular and molecular mechanisms responsible for progression of Barrett's metaplasia to esophageal carcinoma;Beilstein;Gastroenterol Clin North Am,2002

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploiting Matrix Stiffness to Overcome Drug Resistance;ACS Biomaterials Science & Engineering;2024-07-05

2. Strong Annexin A10 Expression Supports a Pancreatic Primary and Combined Annexin A10, Claudin 18, and SOX2 Expression Supports an Esophagogastric Origin in Carcinomas of Unknown Primary;American Journal of Surgical Pathology;2022-11-02

3. Trefoil factor 1 inhibits the development of esophageal adenocarcinoma from Barrett's epithelium;Laboratory Investigation;2022-08

4. Molecular Bases of Mechanisms Accounting for Drug Resistance in Gastric Adenocarcinoma;Cancers;2020-07-30

5. Drug resistance in cancer: mechanisms and tackling strategies;Pharmacological Reports;2020-07-22